Mesterolone (Proviron)

Mesterolone (Proviron) Pls contact:Crystal(at)health-gym(dot)com

CAS:1424-00-6

Molecular Formula: C20H32O2

Molecular weight: 304.47

Assay: 99.5%

Appearance: White crystalline powder.

Usage: Can be used as pharmaceutical material, is often used as an antiestrogenic treatment and may be used by those who have had a poor reaction to testosterone treatments. The drug has shown to be beneficial in treating sexual dysfunction, impotency and low libido. Mesterolons binds to estrogen receptors, reducing their activity, which not only reduces estrogen production, but also encourages natural testosterone production in the body.

Description

Proviron is an oral anabolic steroid, a synthetic product of the male hormone testosterone. The drug has shown value in treating men with mental health issues, such as depression, anxiety and bipolar disorders. The drug also is commonly used to treat sexual dysfunction, including low sperm count. Additionally, Proviron may enhance the effectiveness of other steroids. Interestingly, unlike other steroide, the drug shows little value for bodybuilding, but has the same health risks involved in steroide use for that purpose.

Applications

Proviron is often used as an antiestrogenic treatment and may be used by those who have had a poor reaction to testosterone treatments. The drug has shown to be beneficial in treating sexual dysfunction, impotency and low libido. Mesterolons binds to estrogen receptors, reducing their activity, which not only reduces estrogen production, but also encourages natural testosterone production in the body. During the late 1970s, doctors who performed studies on mesterolon concluded that the drug could be used to treat depression in some men. Patients with symptoms of anxiety and low sex drive reported improvement with low doses of the steroid. During the study, higher doses proved helpful to patients with dysthymia and bipolar depression as well. Since this time, newer studies have shown that patients taking a placebo improved at the same rate as patients taking mesterolon, leading medical professionals to believe that better drug options exit.